Truist Financial’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$345K	Sell	8,570 -500	-6%	-$18.7K	﹤0.01%	2315
2025 Q4	$316K	Buy	9,070 +5,702	+169%	+$448K	﹤0.01%	2292
2025 Q3	$280K	Buy	3,368 +59	+2%	+$4.27K	﹤0.01%	2361
2025 Q2	$243K	Buy	3,309 +631	+24%	+$45.7K	﹤0.01%	2319
2025 Q1	$306K	Buy	+2,678	New	+$163K	﹤0.01%	2136
2024 Q2	–	Sell	-9,246	Closed	-$233K	–	2663
2024 Q1	$233K	Sell	9,246 -5,507	-37%	-$130K	﹤0.01%	2416
2023 Q4	$479K	Sell	14,753 -3,776	-20%	-$104K	﹤0.01%	2004
2023 Q3	$505K	Buy	18,529 +8,711	+89%	+$252K	﹤0.01%	1924
2023 Q2	$218K	Sell	9,818 -21,580	-69%	-$497K	﹤0.01%	2409
2023 Q1	$680K	Buy	31,398 +8,861	+39%	+$194K	﹤0.01%	1782
2022 Q4	$458K	Buy	+22,537	New	+$565K	﹤0.01%	2021
2022 Q3	–	Sell	-15,295	Closed	-$364K	–	2542
2022 Q2	$364K	Hold	15,295	–	–	﹤0.01%	2098
2022 Q1	$344K	Hold	15,295	–	–	﹤0.01%	2228
2021 Q4	$303K	Buy	+15,295	New	+$310K	﹤0.01%	2351
2020 Q4	–	Sell	-28,080	Closed	-$489K	–	2561
2020 Q3	$489K	Sell	28,080 -4,540	-14%	-$72.4K	﹤0.01%	1749
2020 Q2	$549K	Sell	32,620 -3,829	-11%	-$53.8K	﹤0.01%	1571
2020 Q1	$433K	Sell	36,449 -4,133	-10%	-$51.1K	﹤0.01%	1640
2019 Q4	$491K	Buy	+40,582	New	+$565K	﹤0.01%	1881